document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size font family time roman align center collaboration development license agreement style margin margin bottom text indent font size font family time roman this collaboration development license agreement this agreement entered into november nbsp effective date between opco formerly zosano pharma delaware corporation wholly owned subsidiary zosano pharma corporation having place business ardentech court fremont california zosano lilly company indiana corporation with principal place business nbsp lilly nbsp corporate center nbsp indianapolis nbsp indiana lilly style margin margin bottom font size font family time roman align center recital style margin margin bottom text indent font size font family time roman whereas zosano corporation organized operated purpose research development commercialization product based proprietary transdermal drug delivery technology style margin margin bottom text indent font size font family time roman whereas lilly leading global health care company engaged research development commercialization pharmaceutical product style margin margin bottom text indent font size font family time roman whereas zosano completed phase clinical trial defined below patch utilizing microprojection system containing once daily formulation parathyroid hormone phase clinical trial defined below such patch containing once weekly formulation style margin margin bottom text indent font size font family time roman whereas lilly currently market forteo once daily formulation lilly recombinant human analog rhpth administered subcutaneous injection approved united state treatment severe osteoporosis style margin margin bottom text indent font size font family time roman whereas lilly desire obtain from zosano zosano willing grant lilly exclusive worldwide license zosano transdermal microprojection patch technology with once daily other dosing duration formulation accordance with term condition this agreement style margin margin bottom text indent font size font family time roman whereas under this agreement zosano will responsible development activity transdermal microprojection patch technology with once daily other dosing duration formulation including phase clinical trial defined below patch containing once daily formulation provided that zosano will obligated pursue development patch containing dosing formulation other than once daily formulation style margin margin bottom text indent font size font family time roman whereas under this agreement zosano will responsible manufacture commercial supply transdermal microprojection patch technology with once daily formulation style margin margin bottom text indent font size font family time roman whereas concurrently with execution delivery this agreement lilly zosano pharma corporation delaware corporation parent zosano parent entering into common stock purchase agreement pursuant which lilly will purchase parent common stock private placement concurrent with consummation parent first underwritten public offering common stock style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom text indent font size font family time roman therefore consideration foregoing premise mutual covenant contained herein other good valuable consideration receipt sufficiency which hereby acknowledged party agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign definition table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign capitalized term used otherwise defined this agreement shall have meaning ascribed them appendix attached hereto table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign license grant right table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign zosano license lilly subject term condition this agreement zosano hereby grant lilly worldwide royalty bearing exclusive even zosano license with right grant sublicenses solely accordance with section nbsp under licensed technology make have made sell offer sale import otherwise commercialize licensed product field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign implied right right license under intellectual property granted shall granted implication estoppel otherwise under this agreement such right license shall granted only expressly provided term this agreement right expressly granted party under this agreement reserved such party used such party purpose avoidance doubt lilly granted zosano license make have made sell offer sale import lilly forteo style font size vertical align molecule except development activity under this agreement right lilly forteo style font size vertical align trademark other lilly trademark table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sublicensing lilly from after date lilly made first development milestone payment under section nbsp lilly shall entitled without prior consent zosano grant more sublicenses third party right licensed technology granted pursuant section nbsp with respect licensed product provided that such sublicense limited grant right broader than right granted lilly under this agreement lilly affiliate their respective commercialization subcontractor distributor provided however that lilly wish grant sublicenses licensed technology third party then lilly affiliate shall obtain confidential nondisclosure invention assignment agreement with prospective sublicensee that contains term least stringent those term included section nbsp case sublicense such sublicense will exclude right sublicensee further sublicense right granted lilly such sublicensee under sublicense lilly will responsible performance this agreement notwithstanding appointment such sublicensee perform part this agreement failure sublicensee comply with relevant restriction limitation obligation this agreement including payment payment making report keeping book record table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign each such sublicense shall refer this agreement shall subordinate consistent with term condition this agreement shall limit ability lilly fully perform material obligation under this agreement zosano right under this agreement lilly will provide zosano within thirty nbsp after execution copy each such sublicense which zosano share with licensors table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exclusivity each party covenant agrees during term itself with through affiliate third party develop manufacture commercialize field territory product using transdermal patch technology drug delivery system formulation other pharmaceutical formulation useful treat osteoporosis except permitted under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign retained right zosano shall time retain unrestricted right obligation under intellectual property controlled zosano develop manufacture commercialize microprojection array which pierce through outmost stratum corneum layer skin licensed technology itself with third party other than field forth section nothing this agreement shall restrict zosano right develop manufacture commercialize during term dosing duration licensed product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign right engage affiliate third party each party shall have right engage their affiliate third party contractor subcontractor perform portion development commercialization obligation hereunder except that subcontractor debarred disqualified regulatory authority each party shall responsible ensuring that prior engaging subcontractor that such subcontractor subject written agreement containing term condition nbsp consistent with relevant term condition this agreement protecting right party under agreement including imposing obligation confidentiality each such subcontractor nbsp that vest ownership invention developed such subcontractor relating solely licensed product course performing such subcontracted work contracting party nbsp that impose payment obligation liability other party without prior written consent other party nbsp that otherwise consistent with term development plan extent applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign development between party zosano shall zosano cost expense oversee have sole authority responsibility retain final decision making authority over development activity with respect licensed product including implementation development plan attached hereto exhibit development plan shall amended only upon mutual written agreement party provided that zosano amend development plan without such agreement lilly with copy provided lilly within three nbsp with respect amendment addressing discussion with guidance pmda connection with development plan zosano shall commercially reasonable effort achieve critical success factor forth schedule attached hereto zosano shall update joint collaboration committee from table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign time time status development activity including critical success factor data obtained from research program clinical trial using daily product zosano shall provide summary least once every three nbsp month development daily product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign development diligence each party shall perform obligation under development plan professional timely manner compliance with applicable activity under development plan lilly will provide reasonable assistance zosano from time time advancing daily product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign supply material from lilly zosano during term lilly shall supply zosano price placebo filled forteo style font size vertical align filled quantity time determined solely purpose implementing development plan supply agreement pharmacovigilance quality agreement will entered into within sixty nbsp effective date zosano shall shall cause affiliate third party subcontractor solely accordance with term this agreement development plan zosano affiliate permitted subcontractor shall retain possession over such relabel resell provide other third party without lilly prior written consent which consent withheld lilly sole discretion lilly shall provide zosano affiliate their respective sublicensees reasonable assistance training support requested zosano from time time during term zosano expense practice intellectual property owned controlled lilly solely purpose using forth this section nbsp development plan including with respect csfs table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign critical success factor table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party have agreed upon criterion describing indicator success development plan daily product which forth schedule attached hereto critical success factor csfs lilly shall have final decision making authority over whether defined below been achieved table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign first zosano shall conduct patient preference study daily product part development activity accordance with forth more detail exhibit attached hereto patient preference study lilly shall inform zosano writing within thirty nbsp after complete written result from patient preference study have been received lilly whether benchmark patient preference study described therein have been achieved such benchmark have been achieved then lilly shall have right terminate this agreement within fifteen nbsp after complete written result from patient preference study have been received lilly else foregoing termination right with respect patient preference study benchmark shall lapse table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event zosano achieve csfs lilly shall have right terminate this agreement accordance with termination provision forth clause nbsp section nbsp patient preference study subject timeline forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject lilly right reinstatement section nbsp prior lilly payment first development milestone payment under section nbsp zosano determines sole discretion that commercially scientifically unreasonable pursue discontinues development daily product then zosano shall have right terminate this agreement accordance with termination provision forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notwithstanding foregoing prior termination either party under this section nbsp event zosano determines based progress development daily product that should adjusted party shall meet discus good faith reason such termination consider amending this agreement including financial term csfs appropriate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign regulatory patient safety matter party shall come together develop execute safety regulatory agreement said execution shall later than thirty nbsp prior first patient visit interventional interventional clinical trial sponsored zosano including patient preference study safety regulatory agreement shall incorporate term this section further define role responsibility with respect lilly regulatory safety obligation related licensed product lilly ongoing work with forteo including adverse event management reporting exchange safety surveillance signal detection risk management zosano shall zosano cost expense oversee have sole authority responsibility retain final decision making authority over planning implementation control regulatory activity preparation prosecution maintenance zosano name regulatory filing inds regulatory approval licensed product field territory zosano shall solely responsible responding communication related licensed product from regulatory authority field territory after zosano transfer regulatory approval lilly pursuant section nbsp then lilly shall have final decision making authority with regard regulatory issue transferred regulatory approval avoidance doubt lilly shall retain right final decision making authority regulatory safety support investigational application marketing authorization forteo including patient safety pharmacovigilance ownership global safety database role qualified person pharmacovigilance safety surveillance risk management after zosano transfer regulatory approval lilly pursuant section nbsp then lilly shall have final decision making authority with regard regulatory safety issue transferred regulatory approval lilly shall have right perform audit audit zosano safety regulatory activity including each party oversight third party organization contracted perform safety regulatory activity outlined this agreement safety regulatory agreement audit conducted through review documentation data through interview relevant personnel purpose which table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign understand system process place verify compliance practice same frequency audit will more than every three nbsp year except case where lilly reasonable concern initiate cause audit notification intent conduct audit will provided advance within reasonable time period according situation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign coordination lilly shall provide reasonable assistance zosano seeking regulatory approval licensed product forth development plan initially daily product extent lilly receives written material oral communication from pmda other regulatory authority relating regulatory approval with respect licensed product lilly shall notify zosano provide zosano copy material written communication soon reasonably practicable zosano shall provide lilly with draft inds foreign equivalent application regulatory approval licensed product reasonably advance filing that lilly provide comment thereon consideration good faith zosano table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign record each party shall keep complete true accurate book record relating development manufacturing commercialization activity conducted such party under this agreement period required applicable each party cost shall responsible archiving relevant required original documentation notebook data relation development manufacturing commercialization licensed product each party shall adhere internal document record retention policy relating development manufacture commercialization licensed product consistent with applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign right reference upon zosano request lilly shall good faith reasonably consider granting zosano right reference access field territory regulatory filing clinical data information lilly regulatory filing controlled lilly affiliate that necessary obtain regulatory approval licensed product specifically requested regulatory authority related research development manufacture commercialization zosano affiliate their respective sublicensees licensed product under this agreement such right reference shall survive termination expiration this agreement lilly hereby covenant that during term following termination other than lilly pursuant section nbsp hereof expiration this agreement neither affiliate agent acting affiliate behalf shall file cause filed otherwise assert join assist financially otherwise party filing asserting against zosano affiliate their respective subcontractor manufacturer distributor sublicensees agent administrative judicial proceeding claim infringement misappropriation intellectual property right that cover licensed product other claim interfering with zosano right develop manufacture licensed technology field territory seek regulatory approval licensed product under this agreement except precluded under section pursuant section nbsp united state federal food drug cosmetic amended regulation promulgated thereunder right table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign reference granted under this section nbsp shall continue following termination this purpose event violation this covenant lilly agrees that injunctive relief specific performance shall appropriate available remedy addition other remedy available equity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign letter authorization pursuant right reference access provided under section nbsp lilly shall provide letter authorization zosano applicable regulatory agency appropriate under applicable form mutually acceptable zosano lilly within fifteen nbsp request from zosano respect lilly regulatory filing solely connection with research development manufacture including obtaining regulatory approval licensed product field territory under this agreement notwithstanding foregoing lilly shall obligated provide zosano copy lilly forteo style font size vertical align regulatory filing united state food nbsp drug administration more than past five nbsp year such copy shall limited annual report developmental safety update report dsur periodic safety update report psur lilly shall take action reasonably necessary effect such letter authorization right reference access table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory diligence each party shall commercially reasonable effort perform obligation under development plan professional timely manner with respect regulatory obligation lilly shall have right obligation audit review clinical quality system clinical study data clinical research organization engaged zosano carrying development plan table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory approval transfer zosano shall exclusively transfer regulatory approval licensed product lilly order that lilly commercialize licensed product field territory compliance with applicable licensed product approved label transfer regulatory approval shall occur soon possible permit lilly timely commercialize daily product licensed product pursuant compliance with applicable party will work together minimize launch timing optimize commercialization determining most efficient manner transfer regulatory approval including limited transition activity conducted both party each party expense prior receipt regulatory approval lilly hereby grant zosano right reference access such transferred regulatory approval including clinical data information referenced therein solely purpose outside field unrelated treatment osteoporosis zosano shall permitted retain copy such transferred regulatory approval including clinical data information lilly shall provide letter authorization zosano form mutually acceptable zosano lilly within fifteen nbsp request from zosano respect such transferred regulatory approval lilly shall take action reasonably necessary effect such letter authorization right reference access this right reference access lilly obligation under this section nbsp shall survive termination expiration this agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice concerning safety efficacy issue each party shall provide other party with notice within nbsp business after notification other information directly indirectly that receives providing soon reasonably possible copy associated written request that nbsp raise material concern regarding safety efficacy licensed product nbsp indicates suggests third party claim arising connection with licensed product nbsp reasonably likely lead recall licensed product information that shall disclosed extent relates subject matter foregoing clause nbsp through inclusive shall include without limitation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign inspection regulatory authority manufacturing distribution other related facility concerning licensed product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign inquiry regulatory authority concerning clinical investigation activity including inquiry investigator clinical monitoring organization inquires related patient safety other related party with respect licensed product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign material communication form including written oral electronic form from regulatory authority involving manufacture commercialization licensed product other regulatory authority review inquiry relating event forth this section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign initiation regulatory authority investigation detention seizure injunction concerning licensed product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign other regulatory action proposed labeling other registration dossier change recall that would affect licensed product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commercialization diligence lilly shall lilly cost expense responsible shall have final decision making authority planning implementation control commercialization daily product field territory including without limitation whether launch daily product each country territory determining establishing price term sale including rebate discount daily product field each country territory zosano shall provide reasonable assistance lilly initially implementing commercialization daily product following achievement each with respect united state lilly shall commercially reasonable effort commercialize daily product united state following achievement each with respect other country lilly shall commercially reasonable effort commercialize daily product such country compliance with applicable commercialization activity such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacturing zosano shall responsible development scale manufacturing process complete product patch system including applicator packaging manufacturing clinical subject lilly right under section nbsp commercial supply daily product until such time lilly elect assume table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign responsibility manufacture commercial supply daily product under section nbsp zosano shall zosano cost expense responsible shall have final decision making authority except selection manufacturer which shall require lilly consent such consent unreasonably withheld conditioned delayed planning implementation control manufacture daily product field territory aside from management manufacturing operation zosano final decision making authority shall expire upon transfer regulatory approval lilly pursuant section nbsp capital expenditure necessary meet zosano manufacturing responsibility deliver complete product patch system including applicator packaging shall borne zosano lilly shall provide reasonable assistance zosano enable zosano manufacture commercial supply daily product zosano will provide commercial supply complete product patch system including applicator packaging daily product lilly actual manufacturing cost exceed cost therapy product patch system forth table below table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman volume daily product calendar year valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp million valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp million valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp million valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman price therapy valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom margin left font size font family time roman party shall negotiate good faith supply quality agreement incorporating these term within hundred twenty nbsp after first submission regulatory approval daily product territory style margin margin bottom margin left font size font family time roman inspection lilly upon fifteen nbsp prior written notice zosano during normal working hour zosano shall allow lilly authorized representative agent inspect premise zosano their contract manufacturer where daily product manufacturing conducted purpose overseeing auditing manufacture audit provided that such audit nbsp unduly disrupt normal operation zosano business nbsp require zosano provide lilly authorized representative agent confidential information that related manufacture daily product addition party agree that such audit shall conducted more than once every calendar year notwithstanding foregoing sentence lilly shall have right conduct additional audit prior each first commercial sale daily product notwithstanding above sufficient cause which shall communicated writing zosano lilly have immediate access during normal working hour limited extent inspection directly related such cause with appropriate protection preserve confidentiality information applicable facility cause shall mean daily product safety health safety environmental quality issue that been specifically identified mandated regulatory authority where time essence such audit conducted cause shall supplant negate right annual audit style margin margin bottom margin left font size font family time roman zosano shall responsible obtaining active pharmaceutical ingredient required manufacture daily product party acknowledge that effective date zosano current supplier change supplier style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman daily product shall acceptable approved lilly such approval unreasonably withheld conditioned delayed zosano consultation with lilly shall responsible manufacture daily product according specification approved relevant regulatory approval lilly shall have right audit daily product manufacturing site accordance with procedure forth section nbsp lilly shall have right obligation time after transfer regulatory approval lilly pursuant section nbsp assume responsibility commercial manufacturing governance oversight event that lilly elect assume responsibility manufacture commercial supply daily product zosano shall provide reasonable assistance lilly connection therewith style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign joint collaboration committee purpose describing general scope collaboration only subject obligation forth more specifically other section this agreement party contemplate that zosano would responsible management funding further development activity regulatory activity necessary support registration licensed product accordance with development plan event zosano achieves critical success factor lilly shall make applicable milestone payment thereafter solely responsible conduct funding commercialization activity accordingly purpose facilitate periodic communication between party regarding their activity under this agreement will serve alliance decision making body will have power amend waive compliance with term this agreement determine whether party committed breach this agreement avoidance doubt shall have authority determine whether development milestone should pursued amended achieved table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign formation membership soon practicable event more than thirty nbsp after effective date party will form joint collaboration committee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign meeting during term shall meet person least twice calendar year least once every nbsp month time mutually agreed upon party location meeting held person shall alternate between site designated each party other employee each party involved development manufacture commercialization licensed product under this agreement attend meeting with consent each party consultant representative advisor involved development manufacture commercialization licensed product under this agreement attend meeting provided however that such consultant representative advisor under obligation confidentiality applicable confidential information each party that least stringent those forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign membership shall comprised nbsp person from each party party replace representative time upon written table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign notice other party member designate substitute attend perform function that member meeting provided however that each representative shall have sufficient experience expertise development manufacturing commercialization matter pharmaceutical biotechnology industry serve shall have chairperson prior lilly payment first development milestone payment under section nbsp shall representative zosano designated zosano from after lilly payment first development milestone payment under section nbsp shall representative lilly designated lilly shall operate vote with chairperson shall have sole controlling vote table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign responsibility shall have primary responsibility facilitating communication between party regarding development manufacturing commercialization activity shall annually review development plan progress make recommendation modification view current business regulatory condition addition perform such other function appropriate further purpose this agreement mutually agreed writing party chairperson shall responsible preparing circulating agenda advance each meeting preparing issuing minute each meeting promptly thereafter table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign alliance manager each party shall appoint representative posse general understanding this agreement development regulatory commercialization issue alliance manager each alliance manager role alliance manager central point contact between party assure successful relationship between party facilitate flow information resolution dispute accordance with section nbsp that arise request support information from party other will routed through managed alliance manager order minimize disruption both party alliance manager shall active participant attend meeting appropriate requested subcommittee will help agenda facilitate meeting will chairman secretary except with respect voting member subcommittee each party change designated alliance manager from time time upon written notice other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign consideration table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign scope financial term forth this section nbsp only apply daily product subject section nbsp lilly wish commercialize licensed product with dosing duration then party shall negotiate good faith financial term covering additional licensed product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign development milestone payment zosano shall provide lilly with written notice actual first occurrence each development milestone forth below with respect daily product within thirty nbsp after such occurrence upon regulatory approval daily product prior provided table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign that other csfs respect have been achieved lilly shall zosano amount forth next regulatory approval table below within thirty nbsp after first occurrence regulatory approval daily product upon regulatory approval daily product prior provided that other csfs respect have been achieved lilly shall zosano amount forth next regulatory approval table below within thirty nbsp after first occurrence regulatory approval daily product table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman development milestone event daily product valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid payment valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman regulatory approval valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman regulatory approval valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size valign bottom valign bottom nbsp nbsp valign bottom style border solid nbsp valign bottom style border solid nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman total valign bottom font style font size nbsp nbsp font valign bottom valign bottom align right nowrap valign bottom nbsp nbsp style font size valign bottom valign bottom nbsp nbsp valign bottom style border solid nbsp valign bottom style border solid nbsp nbsp table style margin margin bottom margin left font size font family time roman purpose clarity above development milestone payment payable lilly zosano upon achievement such milestone regardless whether regulatory approval first obtained above development milestone payment shall payable only once daily product each payment made zosano pursuant this section nbsp refundable credited against other payment payable lilly zosano under this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign commercial milestone lilly shall provide zosano with written notice actual first occurrence each sale milestone forth below with respect daily product within ninety nbsp after such occurrence within ninety nbsp calendar quarter which such sale milestone been whether lilly affiliate their respective sublicensees lilly shall zosano applicable payment forth below table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman annual sale daily product valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid payment valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman annual worldwide sale greater than valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman annual worldwide sale greater than valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size valign bottom valign bottom nbsp nbsp valign bottom style border solid nbsp valign bottom style border solid nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman total valign bottom font style font size nbsp nbsp font valign bottom valign bottom align right nowrap valign bottom nbsp nbsp style font size valign bottom valign bottom nbsp nbsp valign bottom style border solid nbsp valign bottom style border solid nbsp nbsp table style margin margin bottom margin left font size font family time roman purpose clarity reason sale milestone event forth table above this section nbsp occur prior occurrence subsequent milestone event daily product then skipped milestone event shall deemed occur upon occurrence subsequent milestone event style margin margin bottom margin left font size font family time roman payment forth above this section nbsp shall triggered achievement specified sale daily product first twelve nbsp month calendar period such occurrence shall payable only once despite potential repeated achievement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman specified sale such daily product payment made zosano pursuant this section nbsp refundable credited against other payment payable lilly zosano under this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign rate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign during royalty term lilly shall zosano royalty equal annual calendar year sale daily product united state japan other country royalty rate shall equal provided however that event shall royalty rate country than annual calendar year sale daily product such country royalty floor clarity royalty rate country other than united state japan shall determined accordance with following formula subject royalty floor table style margin margin bottom margin left font size font family time roman style margin margin bottom margin left font size font family time roman purpose foregoing formula mean royalty rate mean mean style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign following royalty term country country basis zosano shall provide commercial supply product patch daily product lilly mark over zosano actual manufacturing cost product patch lilly obligation royalty zosano under section nbsp following royalty term such country shall terminate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty term lilly royalty obligation under section nbsp with respect daily product shall commence country country basis date first commercial sale such daily product lilly affiliate sublicensees relevant country shall expire upon later nbsp expiration last expire valid patent claim licensed technology covering such daily product such country nbsp nbsp year following first commercial sale such daily product such country royalty term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign third party license event either party required obtain more license under intellectual property controlled third party order exercise lilly right licensed patent licensed know country territory contemplated under this agreement zosano shall have first right obligation obtain license such intellectual property term that allow zosano include such intellectual property license granted herein lilly under licensed patent licensed know research develop make have made import export sell offer sale otherwise transfer daily product zosano obtain such license such third party intellectual property then lilly after consultation with zosano shall have right obligation obtain license such third party intellectual property table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign zosano shall responsible paying third party royalty necessary lilly practice license granted section nbsp that relate complete product patch system including applicator device packaging including limited those under alza agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty report royalty payment shall calculated reported paid each calendar quarter after first commercial sale first daily product royalty payment zosano under this agreement shall paid within after each calendar quarter each payment shall accompanied quarterly report sale daily product lilly affiliate their respective sublicensees setting forth sale royalty country country basis well gross sale total deduction adjustment used calculate such sale daily product permit confirmation accuracy payment made zosano hereunder enable zosano comply with reporting obligation under alza agreement lilly shall keep shall cause affiliate their respective sublicensees keep complete accurate book record pertaining sale other disposition daily product which necessary ascertain properly verify payment owed hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign withholding lilly shall withhold from payment zosano amount payment withholding except extent required paid taxing authority with respect such payment lilly shall provide zosano relevant document correspondence shall also provide zosano other cooperation assistance necessary enable zosano claim exemption from such withholding receive full refund such withholding claim foreign credit lilly shall give zosano proper evidence from time time within fifteen nbsp zosano request payment such party shall cooperate with each other seeking deduction under federal state double taxation other similar treaty agreement from time time force table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign interest without limiting other right remedy available zosano lilly agrees interest annual rate month libor maximum interest rate permitted applicable calculated based number overdue good faith undisputed late payment under this section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign wire transfer instruction payment made lilly zosano under this agreement shall made wire transfer from lilly following account zosano table style margin margin bottom margin left font size font family time roman bank silicon valley bank style margin margin bottom margin left font size font family time roman bank address tasman drive santa clara style margin margin bottom margin left font size font family time roman bank account style margin margin bottom margin left font size font family time roman routing nbsp transit style margin margin bottom margin left font size font family time roman swift code style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign term termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign term term this agreement shall commence effective date shall expire country country basis unless earlier terminated under this section nbsp upon date expiration lilly royalty payment obligation under section nbsp hereof respect such country term provided however that provision section nbsp shall survive such expiration respect such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign termination zosano zosano terminate this agreement pursuant section nbsp country country basis upon written notice lilly event determines sole discretion that commercially scientifically unreasonable pursue discontinues development daily product accordance with section nbsp zosano right terminate under this section nbsp expires once lilly make first development milestone payment under section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign termination lilly lilly terminate this agreement nbsp pursuant section nbsp upon written notice zosano event zosano successful meeting nbsp time after first development milestone payment been made under section nbsp upon nbsp month prior written notice zosano table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign termination material breach upon after material breach provision this agreement breaching party terminate this agreement breaching party cured such breach within sixty nbsp period following written notice such breach breaching party notwithstanding foregoing event monetary default default reasonably capable being cured within sixty nbsp cure period defaulting party such defaulting party make good faith effort cure such default cure period shall extended from sixty nbsp ninety nbsp from such original notice default breach remains uncured after aforementioned period time cure such breach then breaching party shall have option terminating this agreement continuing under this agreement which case breaching party shall deemed have waived right terminate this agreement either case breaching party shall entitled recover damage incurred result such breach from breaching party pursuant section nbsp breach remains uncured after aforementioned period time cure such breach breaching party decides terminate this agreement then license granted hereunder shall automatically terminate breaching party shall entitled recover damage incurred result such breach from breaching party right either party terminate this agreement hereinabove provided shall affected waiver failure take action with respect previous default table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effect termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign upon termination this agreement zosano under section nbsp nbsp license hereunder shall automatically terminate nbsp lilly shall retain right reinstatement described section nbsp proposal described section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign upon termination lilly pursuant section nbsp nbsp license hereunder shall automatically terminate nbsp zosano shall retain right develop manufacture commercialize otherwise exploit licensed product nbsp right reinstatement described section nbsp proposal described section nbsp shall each terminate further force effect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign right reinstatement event zosano terminates this agreement pursuant section nbsp subsequently wish restart development activity daily product then shall offer lilly right reinstate term this agreement providing written notice lilly reinstatement offer lilly accepts reinstatement offer providing written notice acceptance zosano within thirty nbsp after lilly receipt reinstatement offer then term this agreement shall reinstated automatically lilly accept reinstatement offer instead proposes zosano writing within thirty nbsp after lilly receipt reinstatement offer financial term daily product zosano accepts such financial term then this agreement will reinstated with such financial term zosano accept lilly proposed financial term then zosano shall enter into agreement develop manufacture commercialize daily product with third party prior august nbsp lilly refuse reinstatement offer fails propose zosano writing within thirty nbsp after lilly receipt reinstatement offer financial term daily product then this agreement shall remain terminated lilly shall have further right reinstatement hereunder zosano shall commercialize daily product prior august nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign dosing duration proposal zosano determines good faith during term this agreement that licensed product with dosing duration would more successful than daily product then zosano shall provide written notice thereof lilly lilly zosano mutually agree proceed with such dosing duration then they shall attempt negotiate financial term development manufacture commercialization such licensed product zosano accepts such financial term then party shall negotiate good faith term definitive agreement development manufacture commercialization such licensed product with dosing duration definitive agreement definitive agreement entered into lilly refuse initial written notice then party will develop such licensed product with dosing duration during term this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign accrued right except otherwise specifically forth this agreement right obligation party shall terminate upon expiration termination this agreement provided however that expiration termination this agreement shall relieve party right obligation accruing prior such expiration termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign return confidential information within thirty nbsp following expiration termination this agreement each party shall promptly return other party destroy confidential information other party copy table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign reproduction thereof addition each party shall destroy nbsp that portion note report other document prepared such party which contain confidential information other party nbsp confidential information other party copy reproduction thereof which electronic form otherwise returned other party notwithstanding foregoing each party representative nbsp retain solely compliance purpose copy confidential information other party order comply with regulation nbsp need destroy electronic archive backup made ordinary course business where would commercially impracticable moreover notwithstanding return destruction confidential information other party each party representative shall continue bound their obligation confidentiality other obligation hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign remedy expiration termination this agreement shall preclude either party from claiming other damage compensation other remedy available that entitled upon such expiration termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign right bankruptcy occurrence insolvency event with respect zosano will itself impact either party license right under this agreement adversely impact right zosano receive royalty milestone right license granted under pursuant this agreement either party other party shall otherwise deemed purpose section nbsp bankruptcy code license right intellectual property defined under bankruptcy code party agree that each party licensee such right under this agreement shall retain fully exercise right election under bankruptcy code party further agree that event commencement bankruptcy proceeding against either party under bankruptcy code subject party other party subject party shall entitled complete duplicate complete access appropriate such intellectual property embodiment such intellectual property shall promptly delivered subject party nbsp upon such commencement bankruptcy proceeding upon subject party written request therefor unless subject party elect continue perform obligation under this agreement nbsp delivered under nbsp above following rejection this agreement behalf subject party upon written request therefor subject party lilly agrees that consideration right granted under license forth section nbsp will zosano royalty milestone payment which would have been payable under this agreement lilly with respect exercise right under license granted this agreement provision this section nbsp without prejudice right that either party have arising under applicable insolvency statute other applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign surviving provision without limiting other provision this agreement that expressly provide certain right obligation under this agreement survive termination expiration this agreement provision section accrued right obligation under this agreement shall survive expiration termination this agreement accordance with their term table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign record audit right table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign during term period nbsp year thereafter lilly shall keep cause affiliate sublicensees keep complete accurate book record pertaining sale other disposition licensed product sufficient detail permit zosano confirm accuracy payment zosano hereunder least three nbsp year following calendar quarter which information relates table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign within term this agreement period nbsp year thereafter zosano shall have right have neutral nationally recognized independent certified public accounting firm selected zosano subject approval lilly such approval unreasonably withheld conditioned delayed inspect more than once each year lilly record three nbsp preceding year purpose determining accuracy royalty milestone payment zosano hereunder period will audited more than once zosano shall submit audit plan including audit scope lilly lilly approval which shall unreasonably withheld conditioned delayed prior audit implementation independent certified public accountant shall keep confidential information obtained during such inspection shall report zosano lilly amount sale royalty milestone payment payable which information zosano share with alza corporation accordance with section nbsp alza agreement well gross sale total deduction adjustment used calculate such sale determined that additional royalty owed that royalty were overpaid during such period lilly will zosano additional royalty zosano will lilly overpaid royalty within thirty nbsp date independent certified public accountant written report received paying party charged such accounting firm will paid zosano unless additional royalty owed exceed five percent nbsp royalty paid royalty period subject audit which case lilly will reasonable accounting firm table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign within term this agreement period nbsp year thereafter lilly shall have right have neutral nationally recognized independent certified public accounting firm selected lilly subject approval zosano such approval unreasonably withheld conditioned delayed inspect more than once each year zosano record three nbsp preceding year purpose determining accuracy manufacturing cost such daily product product patch hereunder relate lilly purchase daily product product patch pursuant section nbsp period will audited more than once lilly shall submit audit plan including audit scope zosano zosano approval which shall unreasonably withheld conditioned delayed prior audit implementation independent certified public accountant shall keep confidential information obtained during such inspection shall report zosano lilly amount manufacturing cost determined that additional money owed table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign overpaid during such period relate lilly purchase daily product product patch pursuant section nbsp supply agreement then owing party shall make payment within thirty nbsp date independent certified public accountant written report received paying party charged such accounting firm will paid lilly unless overage discovered exceeds five percent nbsp amount paid daily product product patch subject audit which case zosano will reasonable accounting firm table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign ownership prosecution intellectual property table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign ownership intellectual property zosano shall exclusively licensed technology lilly hereby assigns agrees assign right title interest licensed technology zosano shall cause employee agent representative advisor consultant lilly affiliate their respective sublicensees execute formal assignment such instrument prepared zosano which zosano deems necessary vest ownership licensed technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign filing prosecution maintenance licensed patent subject provision this section nbsp written agreement existing effective date with respect prosecution licensed patent zosano sole discretion expense will file prosecute maintain determine strategy prosecution licensed patent requested zosano shall timely provide with copy material correspondence from patent authority regarding licensed patent provided such material correspondence obtained from patent authority website zosano shall provide lilly with copy proposed filing with patent authority connection with proceeding before patent authority with licensed patent shall provide lilly reasonable opportunity least nbsp calendar comment such proposed filing with respect such licensed patent which comment zosano shall consider good faith zosano elect discontinue prosecution maintenance licensed patent zosano shall advise lilly writing least sixty nbsp calendar advance such discontinuance requested lilly shall discus with lilly zosano reason such discontinuance requested lilly lilly cost zosano will will authorize lilly take action prevent such abandonment such licensed patent unless zosano material business legal reason taking such action table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign enforcement intellectual property table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice infringement enforcement intellectual property each party shall promptly event within five nbsp business case clause nbsp nbsp below report writing other party during term nbsp known suspected infringement unauthorized challenge licensed technology nbsp certification filed pursuant amendment successor statute thereto claiming table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign that patent right within licensed technology invalid otherwise unenforceable that infringement will arise from manufacture import offer sale sale product third party nbsp without limiting generality section nbsp claim third party that development manufacture commercialization licensed product practice either party licensed technology infringes misappropriates intellectual property right such third party shall provide other party with available evidence supporting such known suspected infringement unauthorized disclosure notification obligation party under this section nbsp understood that information disclosed under such obligation covered provision section nbsp further that neither party shall required such obligation disclose legally privileged information information with respect which such party subject confidentiality other contractual obligation third party unless required operation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign between zosano lilly zosano shall have first right obligation enforce defend licensed patent requested zosano lilly shall reasonably cooperate with zosano zosano cost enforcement defense licensed patent provide zosano reasonable assistance lilly shall kept reasonably advised time such suit proceeding brought zosano with respect licensed patent within thirty nbsp after receiving notice infringement lawsuit validity patent case certification received pursuant either successor provision similar provision country territory other than united state within nbsp business zosano shall determine third party shall institute legal action shall notify lilly such determination zosano fails institute legal action enforce defend licensed patent within aforementioned period then subject right third party enforce licensed patent lilly shall have right obligation cause zosano initiate conduct such legal action lilly sole cost expense zosano institute such legal action desire point such legal action cease continue with such action third party exercise right enforce licensed patent then zosano will provide reasonable written notice lilly prior discontinuing such action foregoing will subject entirety right third party enforce licensed patent under written agreement existing effective date including without limitation alza corporation right under section alza agreement relating infringement claim table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign conduct enforcement lilly required under join such legal action initiated zosano failure lilly become party such suit action proceeding would opinion counsel zosano risk dismissal thereof lilly shall execute paper perform such other reasonably required permit litigation initiated conducted including initiating suit before court tribunal zosano request permitting zosano third party with right enforce licensed patent under written agreement with zosano effective date initiate legal action name itself table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign lilly zosano shall reimburse lilly reasonable pocket expense relating joining thereto participation therein lilly required joined party action initiated zosano then upon request zosano lilly shall waive objection such joinder ground personal jurisdiction venue forum conveniens table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign settlement recovery party enforcing defending licensed patent enter into settlement consent judgment other voluntary final disposition action contemplated this section nbsp without lilly prior consent provided however that nbsp lilly receives general release claim against such proceeding promptly provided thereafter copy such settlement consent judgment other voluntary disposition nbsp such settlement have material adverse impact right granted lilly hereunder scope enforceability licensed patent result payment other liability admission lilly third party other settlement consent judgment voluntary final disposition proceeding under section nbsp party enforcing defending licensed patent shall require prior written consent other party which consent shall unreasonably withheld with respect suit action regarding licensed technology forth above recovery obtained lilly zosano result such proceeding settlement otherwise shall nbsp first used reimburse lilly zosano their reasonable cost legal incurred conduct such proceeding nbsp remaining proceeds shall allocated equally nbsp between party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign trademark lilly shall have sole right develop trademark trade dress connection with commercialization licensed product territory lilly shall such trademark trade dress associated goodwill shall prosecute maintain enforce such trademark trade dress cost discretion lilly shall provide zosano with trademark trade dress information necessary apply regulatory approval party shall cooperate preparation thereof notwithstanding foregoing zosano shall promptly notify lilly known threatened suspected infringement imitation unauthorized unfair competition relating such trademark trade dress shall cooperate with lilly reasonable effort assist lilly protection such trademark trade dress such additional cooperation assistance reasonably requested lilly lilly cost table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign inventorship notwithstanding anything contrary herein inventorship shall determined accordance with patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign indemnification lilly lilly agrees indemnify defend hold harmless zosano affiliate their respective sublicensees officer director employee their respective successor heir assigns zosano indemnitees from against claim cost expense damage liability including reasonable legal cost loss which zosano table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign indemnitees become subject result claim demand action suit other proceeding third party nbsp arising nbsp negligence recklessness wrongful intentional omission lilly affiliate their respective director officer employee agent connection with lilly performance obligation exercise right under this agreement nbsp breach lilly representation warranty covenant forth this agreement nbsp making having made using selling offering sale importing otherwise commercializing licensed product lilly affiliate sublicensees nbsp alleging infringement third party intellectual property right intellectual property owned controlled lilly other than licensed technology development manufacture import export sale offer sale other commercialization licensed product except extent such loss result from nbsp gross negligence willful misconduct zosano nbsp material breach this agreement zosano nbsp claim third party alleging that grant right zosano lilly under this agreement violates conflict with term license other grant right zosano such third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign indemnification zosano zosano shall indemnify defend hold harmless lilly affiliate their respective sublicensees officer director employee their respective successor heir assigns lilly indemnitees from against loss which lilly indemnitees become subject result claim demand action other proceeding third party nbsp arising nbsp negligence recklessness wrongful intentional omission zosano affiliate sublicensees excluding lilly their respective director officer employee agent connection with zosano performance obligation exercise right under this agreement nbsp development manufacture licensed product zosano affiliate subcontractor nbsp breach zosano representation warranty covenant forth this agreement except extent such loss result from nbsp gross negligence willful misconduct lilly nbsp material breach this agreement lilly nbsp claim third party alleging that grant right lilly zosano under this agreement violates conflict with term license other grant right lilly such third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign conduct claim party seeking indemnity first party shall table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign fully promptly notify other party indemnifying party claim proceeding threatened claim proceeding which first party assert indemnification from indemnifying party pursuant this section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign permit indemnifying party insurer indemnifying party expense take full control such claim proceeding with counsel indemnifying party choice reasonably acceptable first party provided however that indemnifying party shall reasonably regularly consult with first party relation progress status such claim proceeding first party participate defense such claim proceeding using counsel choice first party expense table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign reasonably operate with indemnifying party investigation defense such claim proceeding indemnifying party expense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign take reasonable step mitigate loss liability respect such claim proceeding table style margin margin bottom font size font family time roman indemnifying party settle claim proceeding term that provide only monetary relief include general release first party include admission liability impose obligation first party except forth above neither indemnifying party first party shall acknowledge validity compromise otherwise settle claim proceeding without prior written consent other party which consent shall unreasonably withheld conditioned delayed style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation warranty table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign mutual representation warranty covenant each party represents warrant effective date with respect section below covenant other party that table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign corporation duly organized validly existing under jurisdiction incorporation full corporate power legal right authority enter into this agreement carry provision hereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign duly authorized execute deliver this agreement perform obligation hereunder person person executing this agreement behalf been duly authorized requisite corporate action table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign this agreement legally binding upon enforceable accordance with term except limited nbsp applicable bankruptcy insolvency reorganization moratorium fraudulent conveyance other general application relating affecting enforcement creditor right generally nbsp relating availability specific performance injunctive relief other equitable remedy table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign execution delivery performance this agreement conflict with result breach term agreement instrument which party which bound violate material regulation court governmental body administrative other agency having jurisdiction over table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign consent approval authorization order court governmental agency governmental body third party required execution delivery such party this agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign shall during term grant right third party which would conflict material respect with right granted other party hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign engaged litigation arbitration dispute reasonably likely lead litigation arbitration other proceeding which would materially affect validity this agreement ability fulfill obligation under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each employee agent consultant such party engaged performance activity under this agreement shall prior performance such activity under this agreement contractually bound nbsp assign such party right title interest intellectual property arising from activity performed such employee agent consultant under this agreement nbsp comply with confidentiality obligation that least restrictive those forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign zosano representation warranty covenant zosano represents warrant lilly that effective date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign right granted lilly affiliate hereunder conflict with right granted zosano third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign zosano knowledge licensed technology contemplated under this agreement infringe issued patent third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign zosano knowledge aware other patent right know other intellectual property right other than that which licensed hereunder lilly controlled lilly which development manufacture commercialization licensed product contemplated hereunder would infringe table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign control licensed technology field territory there agreement with assignment restriction lien encumbrance dispute with proceeding claim against zosano affiliate relating affecting limiting zosano right with respect licensed technology other than nbsp security interest granted connection with loan security agreement between zosano hercules technology growth capital joinder agreement between parent hercules technology growth capital nbsp security interest granted connection with promissory note zosano parent with direct sotrs assignee biomed realty holding table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign lilly representation warranty lilly represents warrant zosano that effective date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign right granted zosano affiliate hereunder conflict with right granted lilly third party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign lilly knowledge molecule contained therein contemplated under this agreement infringe issued patent third party there agreement with assignment restriction lien encumbrance dispute with proceeding claim against lilly affiliate relating affecting limiting lilly right with respect thereto table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign disclaimer except otherwise expressly provided this agreement neither party make representation extends warranty kind either express implied including warranty design merchantability fitness particular purpose infringement intellectual property right third party arising from course dealing usage trade practice case with respect thereto without limiting generality foregoing each party expressly warrant successful development manufacture commercialization licensed product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign limitation liability except liability breach section nbsp confidentiality without prejudice obligation either party indemnify other party with respect claim third party under section neither party shall entitled recover from other party special incidental consequential punitive other indirect damage connection with this agreement license granted hereunder provided however that this section shall construed limit damage awarded specifically with respect either party gross negligence willful misconduct table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidentiality table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign disclosure proprietary information except extent expressly authorized this agreement otherwise agreed writing party each party agrees hold will cause their respective officer director employee agent attorney accountant consultant advisor agent representative hold including aforementioned employed party affiliate confidence disclose person shall will cause representative purpose other than expressly provided this agreement confidential information furnished other party pursuant this agreement confidential information other party developed part activity hereunder each party such confidential information only extent required purpose this agreement each party shall disclose confidential information other party only representative nbsp have need know such confidential information course performance their duty under this agreement nbsp informed confidential nature confidential information nbsp agree writing enforceable other party comply with term this agreement party hereto otherwise bound table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign obligation confidentiality confidential information least stringent those forth this agreement each party shall adopt maintain program procedure that reasonably calculated protect confidentiality confidential information including maintaining record whom confidential information been disclosed shall responsible other party disclosure misuse confidential information that result from failure comply with term this section nbsp such party such party representative each party shall promptly report other party actual suspected violation term this section nbsp shall take reasonable further step requested other party prevent control remedy such violation breach this section nbsp either party representative shall considered breach such party itself table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign limitation obligation obligation each party specified this section nbsp shall apply such party shall have further obligation with respect confidential information other party that receiving party prove competent written evidence table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign hereafter becomes through failure part receiving party affiliate generally known available public table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign known receiving party affiliate time receiving such information other than result receiving party affiliate breach legal obligation evidenced affiliate record table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign becomes known receiving party affiliate through disclosure matter right without restriction disclosure third party under obligation font style white space nowrap disclosure font disclosing party affiliate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign independently developed receiving party without reference reliance upon confidential information disclosing party evidenced such party written record table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject written permission disclose provided disclosing party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exception each party disclose confidential information belonging other party extent such disclosure necessary following instance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign filing prosecuting patent permitted this agreement order obtain patent right that party expressly permitted obtain under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory filing licensed product permitted this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign prosecuting defending litigation permitted this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign complying with applicable court order complying with oral question interrogatory request information document subpoena civil investigative demand similar process governmental regulation including rule guidance security exchange commission stock exchange including rule guidance internal revenue service taxing authority table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign disclosure third party connection with diligence similar investigation such third party disclosure potential third party investor confidential financing document provided each case that such third party agrees bound reasonable obligation confidentiality table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign zosano provide alza corporation copy this agreement redacted lilly exclude information necessary assessing zosano compliance with alza agreement table style margin margin bottom margin left font size font family time roman provided however that party required make disclosure other party confidential information pursuant this section nbsp shall except where impracticable give reasonable advance notice other party such disclosure request requirement that other party seek appropriate protective order other appropriate remedy waive compliance with provision this agreement party that required make disclosure shall reasonably cooperate with other party such other party sole cost expense obtain such protective order other remedy such order other remedy obtained other party waif compliance with provision this agreement then such party shall only disclose that portion confidential information which advised counsel that legally required disclose shall reasonable effort obtain reliable assurance other party sole cost expense that confidential treatment will accorded confidential information disclosed without limiting generality foregoing party shall consult with each other provision this agreement redacted filing made either party with security exchange commission foreign counterpart otherwise required style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign publication either party proposes publish present result data related development manufacture licensed product licensed technology excluding publication presentation which include only standard source reference licensed technology consistent with scientific journal publication practice then other party shall have right review comment material proposed such publication presentation such oral presentation scientific conference seminar scientific journal manuscript abstract before such material submitted publication presentation proposing party shall deliver complete copy such material other party least thirty nbsp prior proposed submission publication presentation such other party shall reasonable effort give comment proposing party within thirty nbsp following delivery such material with respect oral presentation material abstract such other party shall reasonable effort expedite review such material provide comment proposing party within twenty nbsp following date delivery such material such other party proposing party shall nbsp give consideration editorial comment other party nbsp comply with other party request delete reference such party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign confidential information such material nbsp delay submission publication presentation period additional ninety nbsp purpose preparing filing appropriate patent application accordance with term section nbsp hereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign announcement except expressly permitted this agreement neither party shall issue public announcement press release other public disclosure regarding this agreement subject matter name other party publicity advertising announcement without other party prior written consent except such disclosure that opinion counsel party proposing make such disclosure required advisable rule regulation guidance security exchange commission stock exchange which security such party listed provided that unless prohibited disclosing party will make proposed disclosure available review comment other party such disclosure subject proviso section nbsp extent practicable notwithstanding anything contrary contained this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each party disclose term this agreement other confidential information received from other party legal accounting advisor each case bound obligation confidentiality substantially equivalent scope those forth this section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign soon practicable after effective date zosano issue press release after obtaining lilly written approval table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign term confidentiality confidentiality obligation imposed each party under this section nbsp shall continue with respect particular item confidential information other party until nbsp year after expiration termination this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign miscellaneous provision table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign dispute resolution each party shall have right refer dispute controversy claim connection with this agreement including without limitation related compliance with term this agreement validity breach termination interpretation this agreement senior management within each party resolution dispute will referred alliance manager seek resolution alliance manager unable achieve resolution within matter being referred them then alliance manager will notify chair will convene meeting senior management shall have thirty nbsp which meet good faith resolve dispute controversy claim except those matter which party final decision making authority under section unable resolve matter within thirty nbsp then dispute controversy claim shall submitted promptly chief executive officer zosano delegate business unit president lilly their delegate resolution either party comply with above such senior table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign officer unable resolve dispute controversy claim within thirty nbsp then dispute controversy claim pursued either party under applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign compliance with anti corruption connection with this agreement party including their affiliate subcontractor have complied will comply with applicable local national international regulation industry code dealing with government procurement conflict interest corruption bribery including applicable foreign corrupt practice fcpa amended table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign connection with this agreement party have made offered given promised give authorized will make offer give promise give authorize bribe kickback payment transfer anything value directly indirectly person government public official purpose nbsp improperly influencing decision person government public official nbsp inducing person government public official omit violation lawful otherwise required duty nbsp securing improper advantage nbsp inducing person government public official improperly influence decision organization including government government instrumentality order assist zosano lilly obtaining retaining business table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each party agrees that breach this section agreement shall considered material breach agreement that breaching party immediately seek remedy available under equity including termination this agreement belief good faith that provision this section agreement been breached table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each party agrees that will maintain accurate complete record receipt expense having with payment government public official connection with this agreement accordance with generally accepted accounting principle during term this agreement period five nbsp year thereafter nbsp each party further agrees that will maintain adequate internal control will make permit book account inadequately identified transaction recording existent expenditure entry liability with incorrect identification their object false document connection with this agreement nbsp each party will make such book accounting record available review other party independent party nominated requesting party more than once each year their request table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign governing this agreement shall governed respect state york without regard choice provision table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign equitable relief each party hereto acknowledges that remedy other party breach threatened breach this agreement inadequate recognition this fact either party this agreement without posting table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign bond addition other remedy that available shall entitled seek equitable relief form specific performance temporary restraining order temporary permanent injunction other equitable remedy court competent jurisdiction that then available table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign entire agreement modification this agreement including development plan other schedule exhibit hereto constitutes final expression party agreement complete exclusive statement with respect respective term this agreement supersedes prior contemporaneous agreement communication between party whether oral written otherwise concerning matter contained herein trade custom course dealing course performance party shall relevant modify supplement explain term used this agreement event inconsistency conflict between term this agreement development plan term this agreement shall govern unless such conflicting provision expressly identified disclaimed development plan this agreement modified supplemented purchase order change order acknowledgment order acceptance standard term sale invoice like this agreement only modified amended supplemented writing signed party this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign relationship between party party relationship established this agreement solely that independent contractor this agreement create partnership joint venture similar business relationship between party neither party legal representative other party neither party assume create obligation representation warranty guarantee express implied behalf other party purpose whatsoever table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign waiver failure party insist upon strict performance provision this agreement exercise right arising this agreement shall neither impair that provision right constitute waiver that provision right whole part that instance other instance waiver party particular provision right shall writing shall particular matter applicable particular period time shall signed such party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign assignment except expressly provided hereunder neither this agreement right obligation hereunder assigned otherwise transferred either party without prior written consent other party which consent shall unreasonably withheld provided however that nbsp either party assign this agreement right obligation hereunder affiliate provided that such party shall remain liable responsible other party performance observance such duty obligation such affiliate nbsp either party assign this agreement right obligation hereunder third party connection with transfer sale substantially business such party which this agreement relates whether merger sale stock sale asset otherwise right obligation party under this agreement shall binding upon inure benefit successor permitted assigns party assignment accordance with this agreement shall void table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign third party beneficiary this agreement neither expressly impliedly made benefit party other than those executing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign severability reason part this agreement adjudicated invalid unenforceable illegal court competent jurisdiction then such adjudication shall affect impair whole part validity enforceability legality remaining portion this agreement remaining portion shall remain full force effect original agreement been executed without invalidated unenforceable illegal part table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice notice given under this agreement must writing delivered either nbsp person nbsp method mail postage prepaid requiring return receipt nbsp overnight courier confirmed thereafter party notified address given below address such party previously designated prior written notice other party nbsp sending facsimile email followed delivery method forth nbsp nbsp above notice shall deemed sufficiently given purpose upon earlier nbsp date actual receipt nbsp mailed five business after date postmark nbsp delivered overnight courier next business overnight courier regularly make delivery table style margin margin bottom margin left font size font family time roman lilly notice must addressed style margin margin bottom margin left font size font family time roman lilly company style margin margin bottom margin left font size font family time roman lilly corporate center style margin margin bottom margin left font size font family time roman indianapolis style margin margin bottom margin left font size font family time roman attention president medicine business unit style margin margin bottom margin left font size font family time roman with copy style margin margin bottom margin left font size font family time roman lilly company style margin margin bottom margin left font size font family time roman lilly corporate center style margin margin bottom margin left font size font family time roman indianapolis style margin margin bottom margin left font size font family time roman attention general counsel style margin margin bottom margin left font size font family time roman zosano notice must addressed style margin margin bottom margin left font size font family time roman opco zosano pharma corporation style margin margin bottom margin left font size font family time roman ardentech court style margin margin bottom margin left font size font family time roman fremont california style margin margin bottom margin left font size font family time roman attention chief executive officer style margin margin bottom margin left font size font family time roman facsimile style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman with copy style margin margin bottom margin left font size font family time roman foley hoag style margin margin bottom margin left font size font family time roman seaport blvd style margin margin bottom margin left font size font family time roman boston style margin margin bottom margin left font size font family time roman attention jeff quillen style margin margin bottom margin left font size font family time roman facsimile style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign force majeure except obligation make payment when each party shall excused from liability failure delay performance obligation under this agreement reason event beyond such party reasonable control including limited fire flood explosion earthquake other natural force civil unrest terrorism accident destruction other casualty lack failure transportation facility lack failure supply material strike labor disturbance other event similar those enumerated above such excuse from liability shall effective only extent duration event causing failure delay performance provided that party caused such event occur notice party failure delay performance force majeure shall given other party within thirty nbsp after occurrence delivery date under this agreement that have been affected force majeure shall tolled duration such force majeure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign name except otherwise provided herein nothing contained this agreement shall construed conferring right either party advertising publicity other promotional activity name trade name trademark other designation other party including contraction abbreviation simulation foregoing unless express written permission such other party been obtained unless good faith determination party complies with security disclosure rule guidance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign interpretation this agreement heading convenience only affect interpretation unless context indicates contrary intention table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign schedule attachment exhibit this agreement form part this agreement there inconsistency between this agreement schedule attachment exhibit hereto then this agreement shall prevail unless party have agreed otherwise writing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign reference includes form word limitation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign caption heading section contained this agreement preceding text section section subsection paragraph hereof inserted solely convenience ease reference only shall constitute part this agreement have effect interpretation construction table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign reference shall mean calendar unless otherwise specified table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign word shall will have same meaning used interchangeably table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign reference dollar table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign counterpart this agreement executed counterpart each which shall deemed original document which together with this writing shall deemed instrument delivery executed counterpart signature page this agreement facsimile email scanned copy will effective delivery original executed counterpart this agreement table style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman witness whereof party hereto have duly executed this agreement effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign colspan opco style font size height height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign style font size height colspan style font family time roman font size valign colspan style margin margin bottom border bottom solid font size font family time roman vikram lamba style font family time roman font size valign name valign bottom font style font size nbsp font valign vikram lamba style font family time roman font size valign title valign bottom font style font size nbsp font valign president chief executive officer style font size height colspan style font family time roman font size valign colspan lilly company style font size height height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign style font size height colspan style font family time roman font size valign colspan style margin margin bottom border bottom solid font size font family time roman david rick style font family time roman font size valign name valign bottom font style font size nbsp font valign david rick style font family time roman font size valign title valign bottom font style font size nbsp font valign font style white space nowrap senior nbsp nbsp nbsp president nbsp lilly nbsp medicine font table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center definition style margin margin bottom font size font family time roman affiliate mean with respect party corporation company partnership joint venture other entity which control controlled under common control with such party purpose this definition control entity mean ownership directly indirectly more than fifty percent nbsp outstanding voting security capital stock such entity legal power direct cause direction general management policy entity question style margin margin bottom font size font family time roman alza agreement mean intellectual property license agreement dated october nbsp between alza corporation macroflux corporation predecessor interest zosano letter agreement dated february nbsp between alza corporation zosano amended from time time effect style margin margin bottom font size font family time roman commercialize commercialization mean activity directly specifically relating marketing promoting detailing distributing importing offering sale having sold selling licensed product field territory excluding development manufacturing style margin margin bottom font size font family time roman confidential information party mean trade secret confidential proprietary information whether written oral other form including without limitation business technical scientific commercial information know material report note document analysis data licensed technology information received zosano pursuant alza agreement whether marked otherwise identified trade secret confidential proprietary information data result arising from development activity shall deemed zosano confidential information confidential information shall also include confidential proprietary information exchanged prior date hereof connection with transaction forth this agreement term this agreement shall deemed confidential information both party style margin margin bottom font size font family time roman control controlled mean with respect particular item material information intellectual property possession right whether through ownership license other than operation this agreement control over affiliate with such right grant license sublicenses provided herein other party without violating term agreement with third party style margin margin bottom font size font family time roman cover covered mean with respect licensed product absence ownership license granted under valid patent claim that manufacture offer sale sale importation such licensed product would infringe such valid patent claim style margin margin bottom font size font family time roman daily product mean product patch which intended deliver formulation patient time each style font size margin margin bottom nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman develop development mean research development product process including without limitation nbsp stability testing toxicology pharmacology formulation drug delivery device delivery technology development quality assurance quality control development pharmacokinetic study clinical study each case leading preparation submission filing regulatory approval nbsp preparation submission filing regulatory approval style margin margin bottom font size font family time roman development plan mean plan forth exhibit attached hereto setting forth including limited planning implementation control funding clinical design protocol specification device development daily product united state japan style margin margin bottom font size font family time roman mean united state food drug administration successor agency thereto style margin margin bottom font size font family time roman field mean style margin margin bottom font size font family time roman first commercial sale mean country first commercial sale that country lilly affiliate sublicensee licensed product third party following receipt marketing approval sell such licensed product such country style margin margin bottom font size font family time roman rate mean period commencing effective date until such time party agree otherwise rate annum based yearly time rated hourly basis rate will increased decreased each anniversary effective date percentage equivalent change over preceding twelve month period consumer price index urban wage earner clerical worker rate shall include cost salary benefit supply travel other employee cost supporting general administration allocation clarity rate will apply employee that performs activity related manufacturing cost related such employee will included only extent consistent with definition manufacturing cost style margin margin bottom font size font family time roman government public official mean nbsp nbsp official officer employee representative anyone acting official capacity behalf nbsp nbsp government department agency thereof nbsp public international organization such united nation international monetary fund international cross world health organization department agency institution thereof nbsp government owned controlled company institution other entity including government owned hospital university nbsp political party party official nbsp candidate political office style margin margin bottom font size font family time roman insolvency event mean party becomes insolvent dissolved liquidated file filed against petition bankruptcy reorganization dissolution liquidation similar action filed against adjudicated bankrupt receiver appointed business occur style margin margin bottom font size font family time roman intellectual property intellectual property right mean know patent right style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman mean joint collaboration committee defined section nbsp further described section nbsp style margin margin bottom font size font family time roman know mean idea concept discovery invention development trade secret know technique methodology modification innovation improvement design design concept technical information expertise process specification formula procedure protocol data result other information proprietary relevant party style margin margin bottom font size font family time roman label approval mean approval pmda label substantially form attached hereto exhibit style margin margin bottom font size font family time roman mean statute rule regulation order judgment ordinance governmental authority regulatory authority style margin margin bottom font size font family time roman licensed know mean know that nbsp controlled zosano effective date time during term this agreement that generally known even though part thereof generally known nbsp necessary useful make sell offer sale import licensed product field including without limitation know arising from activity performed under development plan licensed know include licensed patent right style margin margin bottom font size font family time roman licensed patent mean patent right controlled zosano affiliate effective date time during term this agreement that cover claim technology that necessary useful make have made sell offer sale import licensed product field including without limitation patent right arising from activity under development plan licensed patent include licensed know style margin margin bottom font size font family time roman licensed product mean daily product product patch with dosing duration style margin margin bottom font size font family time roman licensed technology mean licensed patent licensed know style margin margin bottom font size font family time roman manufacture manufacturing mean make produce manufacture process fill finish package label perform quality assurance testing release ship store product patch component thereof when used noun manufacture manufacturing mean activity involved manufacturing product patch component thereof style margin margin bottom font size font family time roman manufacturing cost mean fully burdened aggregate direct indirect cost expense incurred recorded zosano manufacturing accordance with gaap consisting solely nbsp nbsp direct labor cost salary wage employee benefit overtime cost shift premium nbsp direct material including material intermediate packaging cost nbsp operating cost facility equipment including start cleaning cost production nbsp quality release process control cost nbsp charge reasonable spoilage scrap rework cost nbsp amount without markup that paid third party nbsp reasonable allocation facility overhead both fixed variable such manufacturing operation including allocable cost administrator manager overseeing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman manufacturing production each case through extent specifically identifiable manufacture product determined accordance with applicable accounting standard style margin margin bottom font size font family time roman sale mean gross amount invoiced lilly affiliate their respective sublicensees third party daily product territory style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign trade quantity cash discount allowed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign discount refund rebate chargebacks retroactive price adjustment other allowance which effectively reduces selling price accordance with generally accepted accounting principle gaap table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign daily product return table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign imposed production sale delivery daily product including without limitation sale excise value added each case extent added sale price table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign wholesaler inventory management table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign compulsory annual imposed pharmaceutical manufacturer government table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign allowance distribution expense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign other similar customary deduction which accordance with generally accepted accounting principle gaap table style margin margin bottom text indent font size font family time roman such amount shall determined from book record lilly sublicensee maintained accordance with gaap case sublicensees such similar accounting principle consistently applied lilly further agrees determining such amount will lilly then current standard procedure methodology including lilly then current standard exchange rate methodology translation foreign currency sale into dollar case sublicensees such similar methodology consistently applied style margin margin bottom font size font family time roman dosing duration shall dosing duration other than once daily with respect product patch licensed product example licensed product administration once daily then once weekly administration would dosing duration style margin margin bottom font size font family time roman party mean zosano lilly either party assigns this agreement affiliate accordance with subject section nbsp party shall include such affiliate such party style margin margin bottom font size font family time roman patent authority mean governmental intergovernmental government authorized body responsible receiving examining issuing extending maintaining patent style margin margin bottom font size font family time roman patent right mean patent patent application continuation continuation part divisionals utility model extension renewal substitution addition thereof reissue revalidations examination thereof including patent issuing there from foreign counterpart thereof style margin margin bottom font size font family time roman mean filled cartridge device nbsp currently marketed lilly administer injection once daily formulation lilly recombinant human analog rhpth nbsp manufactured lilly administer placebo style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman phase clinical trial mean human clinical trial that satisfies requirement phase study defined part nbsp successor regulation equivalent human clinical trial outside style margin margin bottom font size font family time roman phase clinical trial mean human clinical trial that satisfies requirement phase study defined part nbsp successor regulation equivalent human clinical trial outside style margin margin bottom font size font family time roman phase clinical trial mean human clinical trial that satisfies requirement phase study defined part nbsp successor regulation equivalent human clinical trial outside purpose section nbsp phase clinical trial shall include pivotal trial that officially designated phase trial with regulatory authority having jurisdiction that intended serve gather pivotal data that favorable would support regulatory approval regardless whether such trial denominated phase phase phase otherwise denominated style margin margin bottom font size font family time roman pmda mean pharmaceutical medical device agency japan successor agency thereto style margin margin bottom font size font family time roman product patch mean microprojection array which pierce through outmost stratum corneum layer skin either nbsp which microprojections coated with formulation containing active pharmaceutical ingredient deliver such active pharmaceutical ingredient into through skin passive diffusion mediated manner nbsp form pathway diffusion mediated delivery active pharmaceutical ingredient into through skin each nbsp nbsp inclusive applicator device patch packaging purpose clarity product patch shall include dosage timed release formulation style margin margin bottom font size font family time roman reasonable assistance mean assistance that provided party other sole discretion party providing assistance requesting party cost expense after specifically defining task reaching mutual agreement regarding amount time number person rate providing party shall invoice other party quarterly basis payment shall within thirty nbsp style margin margin bottom font size font family time roman regulatory approval mean approval including price reimbursement approval license registration authorization including marketing authorization regulatory authority including label approval style margin margin bottom font size font family time roman regulatory authority mean national supra national regional state local regulatory agency department bureau commission council other governmental entity whose approval authorization necessary whom notice must given prior manufacture distribution import transport sale licensed product such jurisdiction style margin margin bottom font size font family time roman royalty term shall have meaning provided section style margin margin bottom font size font family time roman term shall have meaning provided section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman territory mean world style margin margin bottom font size font family time roman third party mean party other than party their affiliate style margin margin bottom font size font family time roman valid patent claim mean country country basis claim nbsp issued patent within licensed patent that nbsp expired been canceled nbsp been declared invalid unreversed unappealable decision court other appropriate body competent jurisdiction nbsp been admitted invalid unenforceable through reissue disclaimer otherwise nbsp been abandoned nbsp patent application that been pending than seven nbsp year nbsp from effective date patent application pending effective date nbsp from date filing patent application filed after effective date claim patent application that ceased valid claim under clause nbsp preceding sentence because passage time later issue part patent within clause nbsp preceding sentence then shall again considered valid claim effective issuance such patent style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center development plan style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign study table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign phase clinical trial file named protocol synopsis daily phase table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nonclinical study zosano will complete systemic toxicology study prior submission table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign usability study zosano will complete final usability study system design prior first patient dosing phase clinical trial result usability study will comprise part table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign specification table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign clinical patch release specification table style margin margin bottom margin left font size font family time roman style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign applicator release specification table style margin margin bottom margin left font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center patient preference study style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center label style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign rowspan primary nbsp indication valign bottom font style font size nbsp nbsp font valign treatment postmenopausal osteoporosis woman high risk fracture style font family time roman font size valign bottom font style font size nbsp nbsp font valign style font size margin margin bottom nbsp style margin margin bottom font size font family time roman pmda treatment osteoporotic patient high risk fracture style font size height height colspan style font family time roman font size valign target population valign bottom font style font size nbsp nbsp font valign same forteo style font size height height colspan style font family time roman font size valign rowspan dosing nbsp nbsp administration valign bottom font style font size nbsp nbsp font valign single patch applied abdomen using reusable applicator style font family time roman font size valign bottom font style font size nbsp nbsp font valign style font size margin margin bottom nbsp style margin margin bottom font size font family time roman dosing patch administered daily style font family time roman font size valign valign bottom font style font size nbsp nbsp font valign style font size margin margin bottom nbsp style margin margin bottom font size font family time roman patch application time minute style font family time roman font size valign valign bottom font style font size nbsp nbsp font valign style font size margin margin bottom nbsp style margin margin bottom font size font family time roman duration treatment comparable forteo currently month style font size height height colspan style font family time roman font size valign primary nbsp endpoint nbsp efficacy valign bottom font style font size nbsp nbsp font valign percentage increase spine month inferior forteo style font size height height colspan style font family time roman font size valign safety tolerability valign bottom font style font size nbsp nbsp font valign style margin margin bottom margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp increase hypercalcemia versus forteo style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp compared with forteo style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp with regard other patch safety performance accepted comparable versus forteo regulatory authority style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp warning compared forteo style font size height height colspan style font family time roman font size valign valign bottom font style font size nbsp nbsp font valign style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp dermatologic tolerability safety worse than forteo label administration site event include pain swelling erythema localized bruising pruritus minor bleeding injection site however result clinical study forming part patient preference study show tolerability patch that worse than tolerability forteo lilly informs zosano accordance with agreement that been achieved then label language regarding dermatologic tolerability safety shall adjusted reflect performance phase patch style font size height height colspan style font family time roman font size valign nbsp nbsp store nbsp product nbsp shelf nbsp life valign bottom font style font size nbsp nbsp font valign style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp month room temperature stability centigrade table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center critical success factor style margin margin bottom font size font family time roman patient preference study benchmark patient preference study exhibit style margin margin bottom font size font family time roman regulatory approval includes label approval exhibit style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory approval daily product later than table style margin margin bottom margin left text indent font size font family time roman regulatory approval daily product later than style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign approved regulatory package daily product approval applicable table style margin margin bottom font size font family time roman manufacturing style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign process development party agree upon process development plan within month after effective date burden sterile process development plan executed applicable relevant geography leading complete package approved regulatory agency established understanding designation critical process parameter testing method specification table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign performance indicator table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign approved regulatory package table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign executed process development plan robust process development package including critical process parameter table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign equipment qualification process validation stability testing completed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party agree upon device development plan within month after effective date device design control deliverable executed throughout project device development plan audited lilly remediated zosano table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign activity timing sufficiently ahead regulatory submission hold filing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign lilly approval product residual risk summary report that complies with table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign performance indicator table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign review approval risk management plan associated deliverable such fmea fault tree analysis control plan system table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign clinical product supply establishment oversight zosano clinical supply chain meeting agency requirement appropriately representative commercial image product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign performance indicator table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign successful governance oversight audit report zosano table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign successful clinical supply manufactured launch site table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign patch supply meet pmda required requirement have aseptic manufacturing condition carry phase testing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign activity timing time support clinical trial without delay geography table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign commercial supply chain establishment oversight zosano approved commercial supply chain capable supplying annual market demand daily product inclusive applicator packaging first three year post launch agreed upon party later than month after effective date cost product target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign performance indicator table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign commercial supply chain established least month prior expected product approval date allows launch without delay post approval within table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign successful governance oversight audit report including limited lilly audit assessment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign quality system established prior regulatory submission successful regulatory approval inspection table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign supply quality agreement established with contract manufacturer table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sufficient installed capacity meet demand first three year post launch table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign patch manufacturing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign refrigeration requirement storage supply chain table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign meet content uniformity requirement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign month inventory build ahead launch table style margin margin bottom font size font family time roman activity timing commercial supply chain place time support regulatory filing inventory build ahead launch style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission double asterisk denote omission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom logo style margin margin bottom font size font family time roman align center protocol synopsis style margin margin bottom font size font family time roman align center draft style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign title valign bottom font style font size nbsp font valign colspan randomized double blind multi center study comparing safety efficacy zosano transdermal teriparatide patch system forteo treatment postmenopausal osteoporosis style font size height height colspan style font family time roman font size valign sponsor valign bottom font style font size nbsp font valign colspan zosano pharma style font size height height colspan style font family time roman font size valign clinical phase valign bottom font style font size nbsp font valign colspan style font size height height colspan style font family time roman font size valign indication valign bottom font style font size nbsp font valign colspan postmenopausal osteoporosis style font size height height colspan height colspan style font family time roman font size valign objective valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan demonstrate inferior lumbar spine change over year with micro micro compared forteo style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan change over month style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan effect biochemical marker bone turnover style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan safety micro micro relative that forteo style font size height height colspan style font family time roman font size valign endpoint valign bottom font style font size nbsp font valign colspan primary style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan percent change lumbar spine over month style font size height height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign colspan secondary style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan percent change total over month style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan percentage responder term lumbar spine gain over month style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan percent change femoral neck over month style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan percent change third radius over month style font size height height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign colspan exploratory style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan change serum style font size height height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign colspan safety style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan maximal change serum calcium within first hour administration evaluated subgroup patient style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan incidence adverse event style font size height height colspan style font family time roman font size valign trial design valign bottom font style font size nbsp font valign colspan randomized double blind double dummy active controlled parallel group year multi center study with month safety extension style font size height height colspan height colspan style font family time roman font size valign investigational valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan micro patch applied once minute style font size height height colspan height colspan style font family time roman font size valign treatment valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan micro patch applied once minute style font size height height colspan height colspan style font family time roman font size valign comparator valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan forteo teriparatide micro injection once style font size height height colspan height colspan style font family time roman font size valign blinding valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan patient control group will receive sucrose coated patch that identical gross appearance patch style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan patient test investigational treatment group will receive table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign zosano pharma valign bottom font style font size nbsp nbsp font valign align center page valign bottom font style font size nbsp nbsp font valign align right confidential table style page break before always size style color width align center style margin margin bottom logo style margin margin bottom font size font family time roman align center protocol synopsis style margin margin bottom font size font family time roman align center draft style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan identical similar forteo daily injection active placebo will have identical label identical patient will instructed designated person each site involved study assessment style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan because their potential unblind study biochemical marker bone turnover pharmacokinetic sample collected used patch will centrally analyzed result will reported clinical site they will reviewed sponsor without link actual patient number other patient data style font size height height colspan style font family time roman font size valign additional treatment valign bottom font style font size nbsp font valign colspan calcium supplement taken every including preceding examination style font size height height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign colspan vitamin supplement individual will selected basis national recommendation local availability supplement style font size height height colspan style font family time roman font size valign randomization valign bottom font style font size nbsp font valign colspan style font size height height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign colspan subject will stratified prior bisphosphonates style font size height height colspan style font family time roman font size valign study population valign bottom font style font size nbsp font valign colspan postmenopausal woman with prior osteoporotic fracture lumbar spine style font size height height colspan style font family time roman font size valign number subject valign bottom font style font size nbsp font valign colspan subject group these least subject will from japan japanese ancestry style font size height height colspan style font family time roman font size valign eligibility valign bottom font style font size nbsp font valign colspan inclusion criterion style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan woman year older time randomization style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan postmenopausal defined style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan menstrual period least consecutive month prior randomization woman under with menstrual period within past year serum follicle stimulating hormone level font style font family symbol font style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan surgical menopause bilateral oophorectomy with without hysterectomy font style font family symbol font month before randomization style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan prior osteoporotic fracture defined style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan history osteoporotic nonvertebral fracture fracture without high energy trauma location other than face skull after self report style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan least radiologically confirmed vertebral compression fracture documented either screening radiograph prior radiological report style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan lumbar spine score font style font family symbol font determined central imaging facility style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan presence least three evaluable lumbar vertebra assessment determined central imaging facility style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan albumin adjusted serum calcium phosphate uric acid within central normal range style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan urinary calcium creatinine ratio within normal range table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign zosano pharma valign bottom font style font size nbsp nbsp font valign align center page valign bottom font style font size nbsp nbsp font valign align right confidential table style page break before always size style color width align center style margin margin bottom logo style margin margin bottom font size font family time roman align center protocol synopsis style margin margin bottom font size font family time roman align center draft style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan vitamin between subject rescreened after vitamin supplementation style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan within normal limit irrespective thyroid hormone replacement font style font family symbol font nbsp time patient clinically euthyroid should analyzed must within normal limit treatment with thyroxine normalize will exclude patient from randomization style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan body mass index than style font size vertical align style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan able walk without assistance good general health determined medical history physical examination laboratory test style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan able self administer study drug daily injection forteo style font size vertical align apply patch have qualified designee administer daily study drug style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan reachable telephone between study visit follow style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan able understand provide written informed consent participate study understand that they free withdraw from study time style font size height height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign colspan exclusion criterion style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan medical history concurrent illness known impact bone health including hyperparathyroidism hypoparathyroidism hyperthyroidism cushing disease style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan with exception osteoporosis metabolic bone disease including osteomalacia osteogenesis imperfecta paget disease fibrous dysplasia unexplained elevation alkaline phosphatase style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan anemia hemoglobin known hematological blood disorder such hemophilia multiple myeloma style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan history urolithiasis hypercalciuria within past five year style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan serum creatinine style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan active hepatic disease transaminase level xuln style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan stage unstable cardiovascular pulmonary disease style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan autoimmune disease requiring chronic anti inflammatory therapy etanercept disease modifying agent methotrexate glucocorticoid including rheumatoid arthritis inflammatory bowel disease celiac disease psoriasis style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan history contact dermatitis known dermatological disorder that could interfere with study procedure assessment style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan known allergy sensitivity tape adhesive teriparatide analog excipients style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan seizure disorder treated with phenobarbital phenytoin style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan with exception fully resected squamous basal cell carcinoma skin history cancer within previous five year going cancer therapy including external beam implant radiation therapy table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign zosano pharma valign bottom font style font size nbsp nbsp font valign align center page valign bottom font style font size nbsp nbsp font valign align right confidential table style page break before always size style color width align center style margin margin bottom logo style margin margin bottom font size font family time roman align center protocol synopsis style margin margin bottom font size font family time roman align center draft style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan history bone metastasis prior external beam implant radiation therapy involving skeleton history skeletal malignancy style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan other previous ongoing clinically significant illness including neurological psychiatric disease that opinion investigator would have interfered with patient ability comply with study protocol could have prevented patient from completing study style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan condition disease that have interfered with ability have evaluation scan example severe osteoarthritis spine spinal fusion pedicle screw history vertebroplasty degenerative disease that resulted insufficient number evaluable lumbar vertebra lumbar vertebral fracture bilateral replacement style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan known history drug alcohol abuse ongoing drug abuse style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan randomized study drug treatment prior zosano study style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan medication history exclusion style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan investigational drug within planned randomization style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan analog font style font family symbol font month total within month randomization week there were major side effect from style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan fluoride strontium therapy osteoporosis time style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan total bisphosphonate more than month within month prior planned randomization duration between month month acceptable followed period least same duration long acting bisphosphonates especially ibandronate zoledronate recommended dosing interval will considered part treatment period style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan estrogen estrogen related drug example tamoxifen tibolone oral skin patch raloxifene within three month prior planned randomization vaginal estrogen cream allowed style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan calcitonin within month prior planned randomization style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan denosumab within year prior planned randomization style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan current digoxin treatment style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan steroid style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign anabolic steroid androgen within month style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign daily inhaled corticosteroid font style font family symbol font micro beclomethasone equivalent within three month style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign oral parenteral glucocorticoid font style font family symbol font prednisone equivalent within three month table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign zosano pharma valign bottom font style font size nbsp nbsp font valign align center page valign bottom font style font size nbsp nbsp font valign align right confidential table style page break before always size style color width align center style margin margin bottom logo style margin margin bottom font size font family time roman align center protocol synopsis style margin margin bottom font size font family time roman align center draft style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font size height height colspan style font family time roman font size valign center valign bottom font style font size nbsp font valign colspan center north america latin america asia europe africa style font size height height colspan height colspan style font family time roman font size valign study duration valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan twelve month week double blind phase style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan month week open label safety extension patient both treatment group style font size height height colspan height colspan style font family time roman font size valign rowspan efficacy assessment valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan lumbar spine forearm screening week style font family time roman font size valign bottom font style font size nbsp font valign style font size margin margin bottom nbsp style margin margin bottom font size font family time roman valign bottom font style font size nbsp font valign colspan style font size margin margin bottom nbsp style margin margin bottom font size font family time roman biochemical marker bone turnover style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign postprandial week style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign bsap screening week style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan serum screening week style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan spine radiograph only screening assessment subject without documented history osteoporotic fracture radiograph will assessed locally style font size height height colspan height colspan style font family time roman font size valign safety assessment valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan physical exam style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan weight height style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan vital sign including orthostatic heart rate before treatment post dose style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan routine chemistry hematology urinalysis style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan calcium metabolism serum calcium phosphate vitamin calcium creatinine ratio style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan serial assessment serum calcium after patch application after injection post dose subset patient selected site approximately subject style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan pharmacokinetic assessment same subset same time point style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan retention patch residual analysis same subset patient style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan anti antibody week style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan lead time point style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan assessment concomitant medication style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan review adverse event style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan patient topical assessment short questionnaire topical experience limited expected phenomenon such erythema additional adverse experience report needed style font size height height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign colspan topical assessment investigator style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign immediately after patch removal patch application performed site style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign assessment application site prior marked patient style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign valign bottom font style font size nbsp font valign modified draize scale will used table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign zosano pharma valign bottom font style font size nbsp nbsp font valign align center page valign bottom font style font size nbsp nbsp font valign align right confidential table style page break before always size style color width align center style margin margin bottom logo style margin margin bottom font size font family time roman align center protocol synopsis style margin margin bottom font size font family time roman align center draft style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font size height height colspan style font family time roman font size valign study procedure valign bottom font style font size nbsp font valign colspan style margin margin bottom font size font family time roman screening visit style font size margin margin bottom nbsp style margin margin bottom font size font family time roman initial treatment visit style font size margin margin bottom nbsp style margin margin bottom font size font family time roman interim visit week style font size margin margin bottom nbsp style margin margin bottom font size font family time roman termination visit week style font size margin margin bottom nbsp style margin margin bottom font size font family time roman phone call foster compliance every week between visit central evaluation quality control scan style font size margin margin bottom nbsp style margin margin bottom font size font family time roman archiving blood sample allow analysis additional marker bone turnover style font size height height colspan style font family time roman font size valign statistical analysis valign bottom font style font size nbsp font valign colspan style margin margin bottom font size font family time roman primary endpoint study percent change lumbar spine will assessed protocol population inferiority investigational regimen comparator regimen will concluded upper limit sided confidence interval difference between comparator test regimen greater than margin inferiority style font size margin margin bottom nbsp style margin margin bottom font size font family time roman alpha adjustment multiple testing will necessary because sequential testing procedure will applied test inferiority micro dose will performed only inferiority micro dose been concluded table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign zosano pharma valign bottom font style font size nbsp nbsp font valign align center page valign bottom font style font size nbsp nbsp font valign align right confidential table style page break before always size style color width align center style margin margin bottom logo style margin margin bottom font size font family time roman align center protocol synopsis style margin margin bottom font size font family time roman align center draft style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center schedule assessment style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nbsp valign bottom nbsp nbsp valign bottom align center style border bottom solid screening visit valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid double blind treatment valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid extension style font family time roman font size valign week number valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign visit number valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign informed consent valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign inclusion exclusion criterion valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign medical history valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign randomization valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign physical exam valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign weight height valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign vital sign including orthostatic nbsp post dose valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign investigator topical assessment valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign review report patient topical assessment valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign concomitant therapy valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign review used patch study drug valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign chemistry nbsp hematology valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign urinalysis valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign intact valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign serum vitamin valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign serum total calcium phosphate valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign serial calcium phosphate retention patch residual analysis subset patient valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign pharmacokinetic sampling subset patient valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign bone specific alkaline phos bsap valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign serum valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign anti antibody valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign spine radiograph unless fracture criterion otherwise satisfied valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign lead valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign dispense supplement valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign dispense study drug valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign zosano pharma valign bottom nbsp nbsp valign align center page valign bottom nbsp nbsp valign align right confidential table body html text document